Product Description
- Active Ingredient: Pegfilgrastim (6 mg per dose).
- Mechanism of Action: Pegfilgrastim encourages the bone marrow to produce more neutrophils, a type of white blood cell essential for the body's immune system to fight off bacterial infections.
- Uses:
- Reducing the incidence and duration of neutropenia (low white blood cell count) caused by myelosuppressive anti-cancer drugs.
- Decreasing the risk of developing febrile neutropenia (fever with a low white blood cell count).
- Increasing survival rates in patients exposed to high doses of radiation that damage bone marrow.
- Administration: It is administered as a single subcutaneous (under the skin) injection once per chemotherapy cycle, typically at least 24 hours after the last dose of chemotherapy.
- Common Side Effects: The most common side effects include bone pain, joint pain, headache, nausea, and pain or redness at the injection site.
- Important Precautions:
- Inform your doctor if you have sickle cell disease, kidney problems, or lung issues, as this medication may worsen these conditions.
- Do not receive Pegstim within 14 days before or 24 hours after your chemotherapy dose.
- Seek immediate medical attention if you experience signs of an allergic reaction (rash, swelling, difficulty breathing) or signs of an enlarged spleen (left upper abdominal pain or shoulder pain).
Efficient Prevention of Chemotherapy-Induced NeutropeniaPegstim Injection is specifically designed to support cancer patients by reducing the incidence of infection related to low white blood cell count, commonly resulting from chemotherapy. By stimulating the bone marrow to produce more white blood cells, Pegstim lowers infection risk and assists in maintaining the chemotherapy schedule.
Safe and Convenient Pre-filled SyringeEach Pegstim Injection comes in a pre-filled syringe equipped with a safety device to simplify administration and enhance user protection. It's intended for single use only and should be administered subcutaneously under medical supervision. The included leaflet provides essential information for both patients and healthcare professionals.
Strict Storage and Handling RequirementsTo maintain its efficacy, Pegstim should always be stored in a refrigerator at 2C - 8C and must never be frozen. It has a shelf life of 24 months from the manufacturing date, ensuring long-term usability when stored correctly. Proper handling and adherence to usage guidelines are crucial for optimal results.
FAQ's of Pegstim Injection 6 Mg,:
Q: How is Pegstim Injection 6 mg administered?
A: Pegstim Injection 6 mg is given as a subcutaneous (under the skin) injection. It is typically administered by a healthcare professional in a clinical setting, using the pre-filled syringe provided.
Q: What is Pegstim Injection used for?
A: Pegstim Injection is prescribed to cancer patients undergoing chemotherapy to prevent or reduce neutropenia, a condition characterized by a low count of white blood cells, which weakens the immune system.
Q: When should Pegstim Injection be used during chemotherapy?
A: The timing of Pegstim administration should follow your physician's directions, commonly within 24 to 72 hours after completion of chemotherapy to minimize the risk of neutropenia.
Q: Where should Pegstim Injection be stored?
A: Pegstim Injection should be kept refrigerated at temperatures between 2C and 8C. It must not be frozen, and should remain in its original packaging until ready for use to protect it from light.
Q: What should I do if I miss a scheduled dose of Pegstim?
A: If you miss a Pegstim dose, contact your healthcare provider immediately. Do not attempt to administer the missed dose yourself unless instructed by your doctor.
Q: What are the possible side effects of Pegstim Injection?
A: Common side effects may include bone pain, headache, and pain at the injection site. If you experience signs of an allergic reaction or any unusual symptoms, seek medical attention promptly.
Q: What is the primary benefit of using Pegstim Injection during chemotherapy?
A: Pegstim Injection helps maintain healthy white blood cell counts in patients undergoing chemotherapy, thereby reducing the risk of infection and allowing patients to follow their treatment schedules more consistently.